Stakeholders from the Round Table, economists but also representing public authorities, gave themselves an overview of our knowledge of the behavior of the various health players and on the sites to be cleared in the years to come. The difficulty in introducing economic questioning in the regulation of the health system was notably underlined.
Video summary:
– Interview with Pierre-Yves Geoffard, research director at Cnrs. (Audio version available)
– Extracts from the round table:
– Introduction of Michel Mougeot, professor of economics, University of Besançon.
– Intervention by Marie-Odile Carrère, professor of economics, University Lyon 1.
– Intervention by Pierre-Yves Geoffard, research director at Cnrs.
Since 1996 has been discussed each year in Parliament the social security financing bill (Plfss), exercise intended to plan the growth of spending and their financing in order to limit deficits. THE Plfss From 2008 marks the desire for a return to the balance of health spending for 2011. While anti-deficit plans have long obeyed a macroeconomic and accounting logic (derepressures, rationing of the offer) without managing to stem the digging of the deficit of social security, we have been witnessing for a few years a growing reflection on the definition and implementation of incentive policies, based on microeconomic analysis Behaviors of health actors (activity pricing, incentives for generic drugs, medical franchises, etc.).
Stakeholders from the Round Table, economists but also representatives of the public authorities, thus gave themselves an overview of our knowledge on the behavior of the various health players and on the sites to be cleared in the years to come.
The difficulty in introducing economic questioning in the regulation of the health system has been underlined. For many practitioners, medicine cannot be a matter of money and the idea that economic growth does not allow us to finance everything in the same way has had, and still sometimes has difficulty imposing itself. Nevertheless, the analysis “ medico-economic “Has its place today, in particular within the High Authority for Health.
The economic study of health is completely specific by its very object and cannot escape ethical reasoning. Thus, if you have to change your strategy in terms of supporting health expenses, what criterion can we adopt ? How to combine the consideration of efficiency and costs ? In this area, the study of foreign experiences can serve as a basis for discussion. The British, in particular, have done an important work on these questions.
From a more empirical point of view, the impact of the financial participation of users on health expenses was discussed. An experience conducted in the United States in the 1970s has shown that the increase in the financial participation of users significantly reduced ambulatory care expenses, but has no effect on hospital care. However, how far can we go in the matter without giving up objectives of solidarity, risk sharing and equality in access to care ?
Furthermore, if the regulation of demand is necessary, the speakers also stressed that it should be combined with regulation of the care offer. While the way is open to the hospital, advances are currently almost nonexistent with regard to city medicine.
Interview with Pierre-Yves Geoffard, research director, Cnrs.
Interview by Florian Mayneris for The life of ideas.
You can also listen to the interview:
Or download the conference audio file in MP3 format (9.1 MB):
Introduction of Michel Mougeot, professor of economics, University of Besançon.
Intervention by Marie-Odile Carrère, professor of economics, University Lyon 1.
Intervention by Pierre-Yves Geoffard, research director, Cnrs.
– All the podcasts of The life of ideas.